ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Regístrate

¿Ya eres miembro? Iniciar sesión

Los Principales Corredores en Línea

Más Corredores en Línea

Datos
Noticias
Herramientas
Mercados
Descubrir

Hot Features

Follow Feed

Conéctese con traders e inversores en nuestra comunidad Follow Feed.

Flujo de Opciones

Explora datos de opciones completos y utiliza filtros avanzados con Options Flow.

Monitor

Organiza y monitorea tu lista de seguimiento de acciones y activos con Monitor.
Iniciar Sesión Premium IconPremium Help Menu
S&P 500
5,346.99
-0.11%
Dow Jones
38,798.99
-0.22%
US Dollar vs MXN
18.4136
0.00%
Brent Oil
79.395
0.00%
Bitcoin
69,280.00
-0.04%
Registration Strip Icon for discussion Regístrate para interactuar en nuestros foros activos para discutir con inversores de ideas afines.
Regístrate
  1. Inicio
  2. Invertir
  3. Acciones
  4. Estados Unidos
  5. NASDAQ
  6. Realm Therapeutics PLC (RLM)

  7. Realm Therapeutics PLC (RLM) Noticias

RLM

Realm Therapeutics (RLM)

Realm Therapeutics PLC
Fecha:
Ordernar por:
 Showing the most relevant articles for your search:NASDAQ:RLM
FechaHoraFuenteTítuloSímboloCompañía
01/08/201910:52Edgar (US Regulatory)Termination of Registration of a Class of Security Under Section 12(b) (15-12b)NASDAQ:RLMRealm Therapeutics PLC
01/08/201905:01Edgar (US Regulatory)Notice of Effectiveness (effect)NASDAQ:RLMRealm Therapeutics PLC
31/07/201907:02Edgar (US Regulatory)Notification Filed by National Security Exchange to Report the Removal From Listing and Registration of Matured, Redeemed or ...NASDAQ:RLMRealm Therapeutics PLC
31/07/201905:38Edgar (US Regulatory)Report of Foreign Issuer (6-k)NASDAQ:RLMRealm Therapeutics PLC
30/07/201913:32Edgar (US Regulatory)Post-effective Amendment to Registration Statement (pos Am)NASDAQ:RLMRealm Therapeutics PLC
10/04/201910:29Edgar (US Regulatory)Annual and Transition Report (foreign Private Issuer) (20-f)NASDAQ:RLMRealm Therapeutics PLC
10/04/201906:00PR Newswire (US)Realm Therapeutics Announces 2018 Annual Report Available and Form 20-F FilingNASDAQ:RLMRealm Therapeutics PLC
05/04/201915:05PR Newswire (US)Realm Therapeutics Announces Receipt of Nasdaq Listing Determination and Requests HearingNASDAQ:RLMRealm Therapeutics PLC
29/03/201906:00PR Newswire (US)Realm Therapeutics Announces Completion of Assets DisposalNASDAQ:RLMRealm Therapeutics PLC
26/03/201906:00PR Newswire (US)Realm Therapeutics Announces Cancellation of AIM ListingNASDAQ:RLMRealm Therapeutics PLC
15/03/201909:36PR Newswire (US)Realm Therapeutics Announces Result of General MeetingNASDAQ:RLMRealm Therapeutics PLC
15/02/201913:20PR Newswire (US)Realm Therapeutics plc ("Realm Therapeutics", "Realm" or the "Company"), Update on Strategic Review, Proposed Assets Disposal...NASDAQ:RLMRealm Therapeutics PLC
14/02/201915:17Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:RLMRealm Therapeutics PLC
29/11/201806:00PR Newswire (US)Realm Therapeutics Provides Update on Strategic ReviewNASDAQ:RLMRealm Therapeutics PLC
17/09/201806:00PR Newswire (US)Realm Therapeutics Provides Corporate Update and Hires Advisor to Support Strategic Review including Formal Sale ProcessNASDAQ:RLMRealm Therapeutics PLC
15/08/201816:31Edgar (US Regulatory)Statement of Beneficial Ownership (sc 13d)NASDAQ:RLMRealm Therapeutics PLC
14/08/201806:18PR Newswire (US)Realm Therapeutics Reports Top-line Data from Phase 2 Trial of PR022 in Atopic Dermatitis and First Half 2018 Financial Resul...NASDAQ:RLMRealm Therapeutics PLC
08/08/201806:00PR Newswire (US)Realm Therapeutics to Present at the 2018 Wedbush PacGrow Healthcare ConferenceNASDAQ:RLMRealm Therapeutics PLC
07/08/201806:00PR Newswire (US)Realm Therapeutics to Report First Half 2018 Financial ResultsNASDAQ:RLMRealm Therapeutics PLC
19/07/201805:04Edgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:RLMRealm Therapeutics PLC
10/07/201806:00PR Newswire (US)Realm Therapeutics Announces Publication of Pre-Clinical Study Demonstrating Comparable Activity of PR022 and Topical Tofacit...NASDAQ:RLMRealm Therapeutics PLC
05/07/201808:39Edgar (US Regulatory)Confidential Treatment Order (ct Order)NASDAQ:RLMRealm Therapeutics PLC
04/07/201806:01PR Newswire (US)Realm Therapeutics Announces Instructions for Exchanging Listed Ordinary Shares into Nasdaq listed ADSsNASDAQ:RLMRealm Therapeutics PLC
04/07/201806:00PR Newswire (US)Realm Therapeutics Announces U.S. SEC Declares Registration Statement Effective and NASDAQ Approves Listing of ADSs Represent...NASDAQ:RLMRealm Therapeutics PLC
03/07/201813:32Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(4) (424b4)NASDAQ:RLMRealm Therapeutics PLC
03/07/201805:10Edgar (US Regulatory)Securities Registration (foreign Private Issuer) (f-1/a)NASDAQ:RLMRealm Therapeutics PLC
02/07/201817:17Edgar (US Regulatory)Amended Securities Registration (ads, Delayed) (f-6/a)NASDAQ:RLMRealm Therapeutics PLC
 Showing the most relevant articles for your search:NASDAQ:RLM

Su Consulta Reciente

CCOM
SILVER
SILVER
NYSE
VZ
Verizon Communications
NYSE
BAC
Bank of America
FX
USDMXN
US Dollar vs MXN
CCOM
OILBRENT
Brent Oil
PM
XAUUSD
Gold vs US Dollar
NASDAQ
NVDA
NVIDIA
USOTC
BNPQY
BNP Paribas (QX)
NYSE
MRK
Merck
COIN
ETHUSD
Ethereum
FX
EURUSD
Euro vs US Dollar
NYSE
MCD
McDonalds
FX
EURMXN
Euro vs MXN
USI
USTECH100
US Tech 100
NYSE
JPM
JP Morgan Chase
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

México
Empresa
Negocios
Popular
Obtener la aplicación
App Store
Google Play

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones

© 2024 ADVFN PLC - Todos los derechos reservados